Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Y Chu

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
The Lancet. Infectious Diseases|March 6, 2019
Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14-14-2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trialYan Li, Susan Y Chu, Chenyan Yue, et al.
American Journal of Obstetrics and Gynecology|February 22, 2011
Preparing for influenza after 2009 H1N1: special considerations for pregnant women and newbornsSonja A Rasmussen, Dmitry M Kissin, Lorraine F Yeung, et al.
American Journal of Obstetrics and Gynecology|April 16, 2011
Impact of maternal immunization on influenza hospitalizations in infantsKatherine A Poehling, Peter G Szilagyi, Mary A Staat, et al.
Vaccine|April 17, 2016
The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in NepalCristina V Cardemil, Concepcion Estivariz, Laxman Shrestha, et al.
MMWR. Morbidity and Mortality Weekly Report|June 9, 2017
Japanese Encephalitis Surveillance and Immunization - Asia and Western Pacific Regions, 2016James D Heffelfinger, Xi Li, Nyambat Batmunkh, et al.
The Lancet. Infectious Diseases|June 22, 2015
Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trialConcepción F Estívariz, Abhijeet Anand, Howard E Gary, et al.
Vaccine|January 9, 2026
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to standard dose in children 9-23 months old in Uganda, 2019-2022 - final reportScarlett E Lee, Marjorie Najjengo, Anna Shaum, et al.
Obstetrics and Gynecology|March 24, 2010
Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant womenAndreea A Creanga, Tamisha F Johnson, Samuel B Graitcer, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
The Lancet. Infectious Diseases|March 6, 2019
Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14-14-2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trialYan Li, Susan Y Chu, Chenyan Yue, et al.
American Journal of Obstetrics and Gynecology|February 22, 2011
Preparing for influenza after 2009 H1N1: special considerations for pregnant women and newbornsSonja A Rasmussen, Dmitry M Kissin, Lorraine F Yeung, et al.
American Journal of Obstetrics and Gynecology|April 16, 2011
Impact of maternal immunization on influenza hospitalizations in infantsKatherine A Poehling, Peter G Szilagyi, Mary A Staat, et al.
Vaccine|April 17, 2016
The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in NepalCristina V Cardemil, Concepcion Estivariz, Laxman Shrestha, et al.
MMWR. Morbidity and Mortality Weekly Report|June 9, 2017
Japanese Encephalitis Surveillance and Immunization - Asia and Western Pacific Regions, 2016James D Heffelfinger, Xi Li, Nyambat Batmunkh, et al.
The Lancet. Infectious Diseases|June 22, 2015
Immunogenicity of three doses of bivalent, trivalent, or type 1 monovalent oral poliovirus vaccines with a 2 week interval between doses in Bangladesh: an open-label, non-inferiority, randomised, controlled trialConcepción F Estívariz, Abhijeet Anand, Howard E Gary, et al.
Vaccine|January 9, 2026
Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to standard dose in children 9-23 months old in Uganda, 2019-2022 - final reportScarlett E Lee, Marjorie Najjengo, Anna Shaum, et al.
Obstetrics and Gynecology|March 24, 2010
Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant womenAndreea A Creanga, Tamisha F Johnson, Samuel B Graitcer, et al.
Pageof 6